Noble Financial Downgrades Evoke Pharma (EVOK) to Hold
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Price: $11.00 --0%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Noble Financial downgraded Evoke Pharma (NASDAQ: EVOK) from Buy to Hold.
For an analyst ratings summary and ratings history on Evoke Pharma click here. For more ratings news on Evoke Pharma click here.
Shares of Evoke Pharma closed at $2.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
- RBC Capital Downgrades Downer EDI Ltd (DOW:AU) (DNERF) to Sector Perform
- Barclays Downgrades Renault SA (RNO:FP) (RNSDF) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Noble FinancialSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
